This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Bretaris Genuair
  • /
  • Efficacy and Safety of LAS 34273 in Patients With ...
Clinical trial

Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

Read time: 1 mins
Last updated:1st Jul 2006

To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Enrollment: 804
Study Start Date: July 2006
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)

- Experimental:
Aclidinium 200 μg once-daily
- Placebo Comparator: Placebo

Category Value
Study start date 2006-07-01

View full details